Personal information

Biography

My research focuses on innovatively employing the aquatic model organism Xenopus tropicalis. I generate novel CRISPR/Cas9 tools for generating rapid, penetrant and clinically relevant amphibian disease models. Ultimately, we employ these models for rapid potential therapeutic target identification aiming at novel drug development and drug repurposing. Xenopus, CRISPR/Cas9, disease modeling, deep learning and computer vision

Activities

Collapse all

Employment (4)

Ghent University: Ghent, BE

2023-10-01 to present | Senior Post-Doctoral Fellow (Department of Biomedical Molecular Biology)
Employment
Source: Self-asserted source
Thomas Naert

University of Zurich: Zurich, CH

2020-02-01 to 2023-09-30 | Post-Doctoral Fellow (Department of Anatomy)
Employment
Source: Self-asserted source
Thomas Naert

Ghent University: Ghent, BE

2019-06-21 to 2019-12-31 | Post-Doctoral Fellow (Department of Biomedical Molecular Biology)
Employment
Source: Self-asserted source
Thomas Naert

Ghent University: Ghent, BE

2015-01-01 to 2019-06-21 | PhD student (Department of Biomedical Molecular Biology)
Employment
Source: Self-asserted source
Thomas Naert

Education and qualifications (3)

Ghent University: Ghent, BE

2019-06-21 | PhD: Biochemistry and Biotechnology
Education
Source: Self-asserted source
Thomas Naert

Ghent University: Ghent, BE

2014-07-02 | Master of Science: Biochemistry and Biotechnology
Education
Source: Self-asserted source
Thomas Naert

Ghent University: Ghent, BE

2012-07-04 | Bachelor of Science: Biochemistry and Biotechnology
Education
Source: Self-asserted source
Thomas Naert

Professional activities (1)

American Society of Nephrology: Washington, US

Membership
Source: Self-asserted source
Thomas Naert

Funding (7)

Post-Doctoral Fellowship - Morphological and molecular insights into vascular complications of ADPKD

2023-08 to 2025-08 | Grant
PKD Foundation (Kansas City, US)
URL: https://pkdcure.org/research-medical-professionals/research-funding/fellowships/
Source: Self-asserted source
Thomas Naert

MSCA-IF Post-Doctoral Fellowship: XenCAKUT - CRISPR/Cas9 based kidney disease modeling to elucidate novel genetic drivers and therapeutic targets in X. tropicalis

2020-10 to 2022-09 | Grant
European Research Council (Brussels, BE)
URL: https://cordis.europa.eu/project/id/891127/de
Source: Self-asserted source
Thomas Naert

PhD Fellowship: CRISPR/Cas9-based in vivo identification of EZH2 as a therapeutic target in desmoid tumors and small cell lung cancer.

2019-01 to 2019-12 | Grant
Kom op tegen Kanker (Brussel, BE)
URL: https://www.crig.ugent.be/en/news/crig-researchers-awarded-by-kom-op-tegen-kanker-2018
Source: Self-asserted source
Thomas Naert

Identifying targets for therapy in a novel genetic Xenopus model for Familal Adenomatous Polyposis

2015-01-01 to 2018-12-31 | Grant
Belgian Federal Science Policy Office (Brussels, BE)
URL: https://app.dimensions.ai/details/grant/grant.8594102
GRANT_NUMBER:

e1fce744-bee9-4e98-aae6-e349b5a8aca8
Source: Self-asserted source
Thomas Naert via DimensionsWizard

BSCDB: PhD Excellence Award

Award
Belgian Society for Cell and Developmental Biology (Brussels, BE)
Source: Self-asserted source
Thomas Naert

John Gurdon Award

Award
International Xenopus Board (IXB) (Washington DC, US)
Source: Self-asserted source
Thomas Naert

Poster Award – 18th international Xenopus Conference

Award
International Xenopus Board (IXB) (Washington DC, US)
Source: Self-asserted source
Thomas Naert
How many people are using ORCID?